Compare SVRA & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SVRA | CLB |
|---|---|---|
| Founded | 2007 | 1936 |
| Country | United States | United States |
| Employees | N/A | 3300 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 864.2M |
| IPO Year | 2009 | 2023 |
| Metric | SVRA | CLB |
|---|---|---|
| Price | $4.97 | $13.25 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | $7.33 | ★ $12.50 |
| AVG Volume (30 Days) | ★ 1.3M | 460.7K |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $526,520,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $430.87 | $4.75 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.51 |
| 52 Week Low | $1.98 | $9.72 |
| 52 Week High | $7.01 | $20.36 |
| Indicator | SVRA | CLB |
|---|---|---|
| Relative Strength Index (RSI) | 43.97 | 41.22 |
| Support Level | $4.78 | $11.76 |
| Resistance Level | $5.43 | $17.05 |
| Average True Range (ATR) | 0.25 | 0.59 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 38.73 | 22.02 |
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.